PEALS Research
We aim for the highest grade research and knowledge transfer between researchers and stakeholders (policymakers, scientists, practitioners, interest groups, commercial developers, the media, diverse publics). This is used to influence current and future agendas in these stakeholder fields. PEALS draws upon the expertise of social scientists, philosophers, action researchers and theologians as well as scientists and clinicians through an established research network.
We run a lively and varied research programme in PEALS that is both well established
and highly regarded, locally, nationally and internationally. You can find out
more about our current research projects
and completed projects and
also our seminar series and annual symposium, both of which
attract a wide range of prestigious speakers. You can also see details of our research and associated activities in our Annual Reviews.
The PEALS research strategy has two main elements. The first is targeting work
that builds on our established areas of expertise in genetic and reproductive
technologies and in disability studies, and on our growing areas of collaboration
in ageing and nanotechnology. The second is to be responsive to new opportunities.
The work by PEALS collaborators from Durham University on the National
DNA database is an example of the latter in that it extends our involvement
in research beyond the clinical domain into other major areas of the application
of the life sciences, in this case criminal investigations. Both approaches
continue to produce the high quality, interdisciplinary work that is our trademark.
Our recent research funders include Cancer Research UK, the Consumers’ Association, the Co-op Group, the Community Fund (in association with the Restricted Growth Association),the Department of Innovation, Universities and Skills (DIUS), the Economic and Social Research Council, the European Commission (6th framework programme), the Joseph Rowntree Charitable Trust, the Medical Research Council, the Northern Rock Foundation, the Royal Society, Unilever, the Wellcome Trust and the William Leech Charity